Development of chemical proteomics approaches for the identification and characterization of protein-protein interactions mediated by histone and non-histone modifications.

Development and biological activity evaluation of inhibitors targeting protein-protein interactions.

Target identification of bioactive small molecules, peptides, and natural products.

Mapping the proteome-wide ligandability toward drug-like fragments.